Literature DB >> 14760318

Conflict of interest.

David R Holmes1, Brian G Firth, Astrid James, Ron Winslow, Patricia K Hodgson, Gail L Gamble, Richard L Popp, Robert A Harrington.   

Abstract

The clinical research enterprise is increasingly scrutinized, in part because of the issue of conflict of interest. The issue is broad and its implications touch on a wide range of concerns, from the safety of patient care to the viability of a large industry. Numerous constituencies are affected by conflict of interest, and representatives of all of them convened in November 2002 for a one-and-a-half day discussion of the issues as well as possible solutions to both the perception and the actuality of such conflict. Participants included medical journal editors, news reporters, physician investigators, representatives of institutional conflict-of-interest oversight committees, representatives of the medical products industry, and Federal regulators. The resulting manuscript provides a review of the issues as well as desirable ways for each of the players to monitor themselves; each section thus contains provocative recommendations for eliminating conflict of interest to ensure that our vibrant health care system continues to foster exciting new advances to improve patient care.

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2004        PMID: 14760318     DOI: 10.1016/j.ahj.2003.12.001

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  3 in total

1.  Public perceptions of physician - pharmaceutical industry interactions: a systematic review.

Authors:  Janine Arkinson; Anne Holbrook; Wojciech Wiercioch
Journal:  Healthc Policy       Date:  2010-05

2.  How Single Institutional Review Boards Manage Their Own Conflicts of Interest: Findings From a National Interview Study.

Authors:  Ekaterina Pivovarova; Robert L Klitzman; Alexandra Murray; Deborah F Stiles; Paul S Appelbaum; Charles W Lidz
Journal:  Acad Med       Date:  2019-10       Impact factor: 6.893

Review 3.  Bench-to-bedside review: human subjects research--are more standards needed?

Authors:  David T Huang; Mehrnaz Hadian
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.